🚀 VC round data is live in beta, check it out!
Scandinavian Real Heart Valuation Multiples
Discover revenue and EBITDA valuation multiples for Scandinavian Real Heart and similar public comparables like Trinity Biotech, Scandinavian Medical, Lifecare, Bionano Genomics and more.
Scandinavian Real Heart Overview
About Scandinavian Real Heart
Scandinavian Real Heart AB is engaged in developing an artificial heart that mimics the shape, function, and bloodflow pattern of the human heart.
Founded
1999
HQ
Employees
12
Website
Sectors
Financials (FY)
EV
$12M
Scandinavian Real Heart Financials
Scandinavian Real Heart reported last fiscal year revenue of — and negative EBITDA of ($4M).
In the same fiscal year, Scandinavian Real Heart generated $3M in gross profit, ($4M) in EBITDA losses, and had net loss of ($4M).
Scandinavian Real Heart P&L
In the most recent fiscal year, Scandinavian Real Heart reported revenue of — and EBITDA of ($4M).
Scandinavian Real Heart expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Gross Profit | — | XXX | $3M | XXX | XXX | XXX |
| EBITDA | — | XXX | ($4M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($4M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Scandinavian Real Heart Stock Performance
Scandinavian Real Heart has current market cap of $14M, and enterprise value of $12M.
Market Cap Evolution
Scandinavian Real Heart's stock price is $1.62.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12M | $14M | 0.3% | XXX | XXX | XXX | $-0.46 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialScandinavian Real Heart Valuation Multiples
Scandinavian Real Heart trades at (3.3x) EV/EBITDA.
Scandinavian Real Heart Financial Valuation Multiples
As of April 19, 2026, Scandinavian Real Heart has market cap of $14M and EV of $12M.
Equity research analysts estimate Scandinavian Real Heart's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Scandinavian Real Heart has a P/E ratio of (3.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $14M | XXX | $14M | XXX | XXX | XXX |
| EV (current) | $12M | XXX | $12M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (3.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (7.4x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.3x | XXX | XXX | XXX |
| P/E | — | XXX | (3.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Scandinavian Real Heart Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Scandinavian Real Heart Margins & Growth Rates
Scandinavian Real Heart's revenue in the last fiscal year grew by —.
Scandinavian Real Heart's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.
Scandinavian Real Heart Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 4% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Scandinavian Real Heart Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Scandinavian Real Heart | XXX | XXX | XXX | XXX | XXX | XXX |
| Trinity Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Scandinavian Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Lifecare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bionano Genomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Arcoma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Scandinavian Real Heart M&A Activity
Scandinavian Real Heart acquired XXX companies to date.
Last acquisition by Scandinavian Real Heart was on XXXXXXXX, XXXXX. Scandinavian Real Heart acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Scandinavian Real Heart
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialScandinavian Real Heart Investment Activity
Scandinavian Real Heart invested in XXX companies to date.
Scandinavian Real Heart made its latest investment on XXXXXXXX, XXXXX. Scandinavian Real Heart invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Scandinavian Real Heart
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Scandinavian Real Heart
| When was Scandinavian Real Heart founded? | Scandinavian Real Heart was founded in 1999. |
| Where is Scandinavian Real Heart headquartered? | Scandinavian Real Heart is headquartered in Sweden. |
| How many employees does Scandinavian Real Heart have? | As of today, Scandinavian Real Heart has over 12 employees. |
| Is Scandinavian Real Heart publicly listed? | Yes, Scandinavian Real Heart is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Scandinavian Real Heart? | Scandinavian Real Heart trades under HEART ticker. |
| When did Scandinavian Real Heart go public? | Scandinavian Real Heart went public in 2014. |
| Who are competitors of Scandinavian Real Heart? | Scandinavian Real Heart main competitors are Trinity Biotech, Scandinavian Medical, Lifecare, Bionano Genomics. |
| What is the current market cap of Scandinavian Real Heart? | Scandinavian Real Heart's current market cap is $14M. |
| Is Scandinavian Real Heart profitable? | No, Scandinavian Real Heart is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.